ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-446 Cr | ₹-649 Cr | ₹-688 Cr | ₹-893 Cr | ₹-751 Cr |
What is the latest Total Non-Current Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹-446 Cr |
| Mar2024 | ₹-649 Cr |
| Mar2023 | ₹-688 Cr |
| Mar2022 | ₹-893 Cr |
| Mar2021 | ₹-751 Cr |
How is Total Non-Current Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-446 Cr | Negative | |
| Mar2024 | ₹-649 Cr | Negative | |
| Mar2023 | ₹-688 Cr | Negative | |
| Mar2022 | ₹-893 Cr | Negative | |
| Mar2021 | ₹-751 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹63,366.5 Cr | -0.9% | -1.8% | 6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,555.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,889.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,073.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,133.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹98,492.9 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -0.9% |
-1.8% |
6% |
| SENSEX | -2.6% |
-10.2% |
-1.6% |
You may also like the below Video Courses